AR013222A1 - Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados. - Google Patents

Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados.

Info

Publication number
AR013222A1
AR013222A1 ARP980103452A ARP980103452A AR013222A1 AR 013222 A1 AR013222 A1 AR 013222A1 AR P980103452 A ARP980103452 A AR P980103452A AR P980103452 A ARP980103452 A AR P980103452A AR 013222 A1 AR013222 A1 AR 013222A1
Authority
AR
Argentina
Prior art keywords
derivatives
substituted
intermediate compounds
oxadiazolil
benzodiacepine
Prior art date
Application number
ARP980103452A
Other languages
English (en)
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of AR013222A1 publication Critical patent/AR013222A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se trata de derivados 5-sustituído-3-oxadiazolil-1,6-naftiridin-2(1H)-ona de la formula I; en la cual Het es oxadiazolico, R1 es H, alquilo inferior,alquilo ciclo-inferior, trifluorometilo, alquenilo inferior, alquinilo inferior alcoxi inferior,al quilo alcoxi-inferior inferior, alquilo hidroxi-inferior,arilo sustituído o no sustituído, grupo heteroaromático sustituído o no sustituído, y R2 es H, alquilo inferior, alquilo ciclo-inferior, alquilmetilociclo-inferior, alqueniloinferior, alquenilo ciclo-inferior, alquinilo inferior, arilo sustituído o no sustituído, o grupo heteroaromático sustituídoo no sustituído, o una sal de adicion de ácido parmacéuticamente aceptable del mismo agonista inverso de labenzodiacepina, por ejemplo, como drogapsicoanaléptica o como droga para el tratamiento de dismencia senil o el mal de Alzheimer. También se preparan compuestos intermediarios para la síntesis dedichos derivados y composiciones y drogas queincluyen dichos derivados
ARP980103452A 1997-07-15 1998-07-15 Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados. AR013222A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20717997 1997-07-15

Publications (1)

Publication Number Publication Date
AR013222A1 true AR013222A1 (es) 2000-12-13

Family

ID=16535559

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103452A AR013222A1 (es) 1997-07-15 1998-07-15 Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados.

Country Status (29)

Country Link
US (2) US6172079B1 (es)
EP (1) EP1010699B1 (es)
JP (1) JP3390453B2 (es)
KR (1) KR100508392B1 (es)
CN (1) CN1134437C (es)
AR (1) AR013222A1 (es)
AT (1) ATE297923T1 (es)
AU (1) AU735960B2 (es)
BR (1) BR9811474B1 (es)
CA (1) CA2296427C (es)
DE (1) DE69830595T2 (es)
DK (1) DK1010699T3 (es)
EE (1) EE04372B1 (es)
ES (1) ES2244065T3 (es)
HK (1) HK1028895A1 (es)
HU (1) HUP0004671A3 (es)
ID (1) ID24047A (es)
IL (2) IL133512A0 (es)
NO (1) NO314999B1 (es)
NZ (1) NZ501814A (es)
PL (1) PL191200B1 (es)
PT (1) PT1010699E (es)
RU (1) RU2188199C2 (es)
SI (1) SI1010699T1 (es)
SK (1) SK285913B6 (es)
TR (1) TR200000103T2 (es)
TW (1) TW486479B (es)
WO (1) WO1999003857A1 (es)
ZA (1) ZA985870B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI298068B (en) * 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
CN101541311B (zh) 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
MX2010009207A (es) * 2008-02-22 2011-03-03 Irm Llc Compuestos y composiciones heterociclicos como inhibidores de c-kit y pdgfr cinasa.
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415580A (en) 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
AU1625192A (en) * 1991-05-31 1992-12-03 Zeneca Limited Heterocyclic derivatives
AU664912B2 (en) * 1992-09-02 1995-12-07 Dainippon Pharmaceutical Co. Ltd. Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
JP2002241379A (ja) * 1997-03-21 2002-08-28 Dainippon Pharmaceut Co Ltd 3−オキサジアゾリルキノキサリン誘導体

Also Published As

Publication number Publication date
US6277993B1 (en) 2001-08-21
TR200000103T2 (tr) 2000-06-21
PL338085A1 (en) 2000-09-25
EP1010699B1 (en) 2005-06-15
CN1264380A (zh) 2000-08-23
IL133512A0 (en) 2001-04-30
ES2244065T3 (es) 2005-12-01
CA2296427A1 (en) 1999-01-28
DK1010699T3 (da) 2005-10-10
ZA985870B (en) 1999-01-27
PT1010699E (pt) 2005-08-31
EE200000029A (et) 2000-10-16
DE69830595D1 (de) 2005-07-21
HK1028895A1 (en) 2001-03-09
EP1010699A4 (en) 2001-09-12
AU735960B2 (en) 2001-07-19
RU2188199C2 (ru) 2002-08-27
BR9811474B1 (pt) 2009-05-05
BR9811474A (pt) 2000-08-15
SK285913B6 (sk) 2007-11-02
HUP0004671A3 (en) 2001-12-28
JP3390453B2 (ja) 2003-03-24
ID24047A (id) 2000-07-06
SK532000A3 (en) 2000-09-12
AU8129498A (en) 1999-02-10
CA2296427C (en) 2006-11-14
US6172079B1 (en) 2001-01-09
NO20000183L (no) 2000-03-07
HUP0004671A2 (hu) 2001-05-28
WO1999003857A1 (fr) 1999-01-28
KR100508392B1 (ko) 2005-08-17
NO20000183D0 (no) 2000-01-14
ATE297923T1 (de) 2005-07-15
CN1134437C (zh) 2004-01-14
PL191200B1 (pl) 2006-03-31
EE04372B1 (et) 2004-10-15
NO314999B1 (no) 2003-06-23
KR20010021824A (ko) 2001-03-15
TW486479B (en) 2002-05-11
EP1010699A1 (en) 2000-06-21
SI1010699T1 (en) 2005-10-31
IL133512A (en) 2007-06-17
DE69830595T2 (de) 2006-05-11
NZ501814A (en) 2002-02-01

Similar Documents

Publication Publication Date Title
SI3002283T1 (en) Thiazole derivatives
DE69021472D1 (de) Pyrazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellung.
ECSP056115A (es) ANTAGONISTAS DEL RECEPTOR A2a DE 2-ALQUINIL- Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA ADENOSINA
BRPI0008128B8 (pt) derivados de quinazolina, composições farmacêuticas contendo os mesmos, e, uso dos mesmos como inibidores de angiogênese
RU94030499A (ru) Тетрагидроизохинолиновые соединения, их о-ацилированные производные, способ получения, фармацевтическая композиция, способ лечения
BRPI0507757A (pt) composto, composição farmacêutica, e agente terapêutico para uma doença na qual a angiogênese ou a hipermeabilidade vascular está envolvida
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
DE69839753D1 (de) 2-(Arylphenyl)amino-imidazolin-Derivate
KR930000483A (ko) [(아릴알킬피페리딘-4-일)메틸]-2a,3,4,5-테트라 하이드로-1(2H)-아세나프틸렌-1-온 및 관련 화합물, 이의 제조방법 및 약제로서의 이의 용도
AR013222A1 (es) Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados.
KR890016013A (ko) 이환식 아민화합물 및 그 제조방법
ES2206604T3 (es) Inhibidores de la neurotoxicidad del acido kainico y derivados de la piridotiazina.
KR930006024A (ko) 이미다조 인돌리진 유도체 및 그의 제조방법
AU679723B2 (en) Diarylalkyl piperidines useful as multi-drug resistant tumoragents
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
US10166236B2 (en) Pharmaceutical formulations comprising substituted pyrazolo[5,1-c]pyrido[4,3-e][1,2,4]triazines for treating lysosomal storage disorders
RU98106104A (ru) Производные пиримидина
BR0111799A (pt) Medicamentos para a prevenção e o tratamento de doenças neurodegenerativas
KR970702272A (ko) 벤즈옥사제핀 유도체, 이의 염 및 이를 함유하는 약제(Benzoxazepine derivatives, salts thereof, and drugs containing the same)
FR2841243A1 (fr) Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27091A1 (fr) Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AR011136A1 (es) Compuesto derivado 4-aminoalcoxi-1h-benzoimidazoles, composicion farmaceutica que lo contiene y el uso del mismo para la fabricacion de unmedicamento
KR950008509A (ko) 인돌릴알킬-피리디닐 및 피리미디닐피페파라진의 항편두통 사이클로부텐디온 유도체
NO20013480D0 (no) Legemiddel for törr hud
KR930019640A (ko) 테트라히드로피리미딘 유도체

Legal Events

Date Code Title Description
FG Grant, registration